Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$12.1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 21 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 27 most recent Form 4 transactions.
| Jul 1 | RPRX | Royalty Pharma plc | SSELL◷ | 9,099 | $55.88 | $508.5K | -100.0% | Open the original filing on SEC.gov |
| Jun 24 | RPRX | Royalty Pharma plc | SSELL◷ | 9,098 | $55.18 | $502.1K | -50.0% | Open the original filing on SEC.gov |
| May 20 | RPRX | Royalty Pharma plc | SSELL◷ | 13,684 | $52.75 | $721.8K | -42.9% | Open the original filing on SEC.gov |
| May 14 | RPRX | Royalty Pharma plc | SSELL◷ | 13,684 | $53.06 | $726.1K | -30.0% | Open the original filing on SEC.gov |
| May 6 | RPRX | Royalty Pharma plc | AGRANT | 18,197 | — | — | +66.5% | Open the original filing on SEC.gov |
| Feb 11 | RPRX | Royalty Pharma plc | AGRANT | 19,970 | — | — | +269.9% | Open the original filing on SEC.gov |
| Jan 30 | RPRX | Royalty Pharma plc | SSELL◷ | 20,000 | $41.09 | $821.8K | -100.0% | Open the original filing on SEC.gov |
| Jan 23 | RPRX | Royalty Pharma plc | SSELL◷ | 20,000 | $40.26 | $805.1K | -50.0% | Open the original filing on SEC.gov |
| Jan 16 | RPRX | Royalty Pharma plc | SSELL◷ | 20,000 | $39.52 | $790.3K | -33.3% | Open the original filing on SEC.gov |
| Jan 9 | RPRX | Royalty Pharma plc | SSELL◷ | 20,000 | $40.78 | $815.6K | -25.0% | Open the original filing on SEC.gov |
| Jan 2 | RPRX | Royalty Pharma plc | SSELL◷ | 20,000 | $38.48 | $769.7K | -20.0% | Open the original filing on SEC.gov |
| Dec 26, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 20,000 | $39.32 | $786.4K | -16.7% | Open the original filing on SEC.gov |
| Dec 19, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 20,000 | $38.38 | $767.6K | -14.3% | Open the original filing on SEC.gov |
| Dec 16, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 20,000 | $38.32 | $766.4K | -12.5% | Open the original filing on SEC.gov |
| Dec 5, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 18,242 | $39.15 | $714.2K | -71.2% | Open the original filing on SEC.gov |
| Dec 5, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 23,334 | $39.15 | $913.6K | -12.7% | Open the original filing on SEC.gov |
| Dec 1, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 18,242 | $39.90 | $727.9K | -41.6% | Open the original filing on SEC.gov |
| Dec 1, 2025 | RPRX | Royalty Pharma plc | SSELL◷ | 23,333 | $39.93 | $931.6K | -11.3% | Open the original filing on SEC.gov |
| Nov 7, 2025 | RPRX | Royalty Pharma plc | CCONV◆ | 16,000 | — | — | — | Open the original filing on SEC.gov |
| Nov 7, 2025 | RPRX | Royalty Pharma plc | CCONV | 160,000 | — | — | +342.9% | Open the original filing on SEC.gov |
| Nov 5, 2025 | RPRX | Royalty Pharma plc | AGRANT | 4,626 | — | — | +11.8% | Open the original filing on SEC.gov |
| Aug 8, 2025 | RPRX | Royalty Pharma plc | GGIFT◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 6, 2025 | RPRX | Royalty Pharma plc | AGRANT | 2,772 | — | — | +7.6% | Open the original filing on SEC.gov |
| May 16, 2025 | RPRX | Royalty Pharma plc | AGRANT◆ | 1.4M | — | — | — | Open the original filing on SEC.gov |
| May 8, 2025 | RPRX | Royalty Pharma plc | AGRANT | 36,484 | — | — | +78.2% | Open the original filing on SEC.gov |